Eaton’s Vehicle Group Facilities Aim to Minimize Environmental Impact With New Technologies and Systems
15.10.2020 16:00:00 EEST | Business Wire | Press release
Power management company Eaton today announced its Vehicle Group is installing a variety of sustainable technologies, including energy efficient lighting systems, water conservation equipment and energy-generating solar panels, at its global manufacturing facilities to reduce the company’s environmental footprint.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201015005246/en/
Eaton’s Vehicle Group site in Jining, China, installed a solar roof to generate electricity for the facility. (Photo: Business Wire)
Reducing water consumption and pollutants
To reduce water consumption and mitigate pollutants, Eaton’s Vehicle Group is installing wastewater systems featuring ultrafiltration and reverse osmosis technologies for the treatment of industrial process water at several of its facilities. The systems are designed to treat and reuse water for industrial purposes.
In addition, some facilities are managing their stormwater by increasing the permeability of their property, decreasing runoff rates to reduce erosion, and adding native plantings that don’t require watering.
Employees at Vehicle Group’s Valinhos, Brazil, facility initiated an innovative water conservation system that treats water used at the plant with physicochemical and biological processes. The treated water is then reused in restrooms and for cleaning. In the first month of operation the system saved 40 cubic meters of water and is projected to increase to 129 cubic meters of water savings per month as the process is refined.
Multiple Vehicle Group sites also have made progress in diverting grinding swarf waste from landfills. Swarf, a byproduct generated during metal-cutting processes when fluids such as oils, coolants and water are mixed with fine particles of metal and filtration media, is one of the most difficult waste streams to recycle. Through vendor partnerships, the Vehicle Group deployed a mobile centrifuge process that separates the materials, making it possible to reuse the fluid during manufacturing processes and recycle the metal particles.
Leveraging innovative technologies to reduce energy consumption
New lighting systems composed entirely of light-emitting diodes (LEDs), which utilize 70 percent less energy than traditional lighting technologies, are being added at Eaton’s Vehicle Group facilities. The LEDs are activated by motion sensors that detect when someone enters or exits an area and a wireless control system that manages every lighting fixture and tracks the status of each. The Vehicle Group’s Tczew, Poland, facility recently installed such a system and has already realized a large reduction in energy consumption resulting in savings of hundreds of dollars in monthly costs.
Many of the electrical systems within a facility are sourced from Eaton’s Electrical Sector, a global leader in power distribution, power quality, industrial automation and power control product and service solutions.
In addition to leveraging LEDs, some Vehicle Group sites are taking steps to produce their own power by installing massive solar panels on the roof. A 10,000-square-meter solar panel array was recently installed on the rooftop of the Vehicle Group’s Wuxi, China, facility, and it’s expected to generate 769 MWh of electrical power annually. Electricity generated will be used for manufacturing at the plant, reducing greenhouse gases by about 588 tons per year. Additionally, solar roofs were installed in the Nashik and Ranjangaon, India, plants, reducing more than a 1,000 tons of carbon dioxide emissions annually.
Constructed from the ground up with an environmental focus
The manufacturing facility in Aguascalientes, Mexico, was constructed with a number of new environmentally focused features, including motorized windows for natural ventilation, reflective roofs for low solar gain and a daylight harvesting system that uses natural light to minimize energy consumption.
The site features a lighting system composed entirely of LEDs, a cooling system with motorized windows for natural ventilation and a reflective roof to reduce heat detention, while dryers and a mist eliminator ensure quality air flows through the plant.
Driving the movement toward a circular economy
Eaton is joining the global movement to mitigate climate change, which includes science-based targets for cutting carbon emissions from the company’s operations by at least 50 percent by 2030, positioning Eaton to achieve carbon neutrality.
Eaton’s eMobility business is contributing to a carbon-free future by installing vehicle charging ports for electrified vehicles at all its global sites, which encourages employees to choose zero-emission cars for their workplace commute.
In an effort to reduce waste, Eaton also is committed to achieving zero waste-to-landfill (ZWTL) status at 100 percent of its manufacturing facilities by 2030, and the Vehicle Group is doing its part to contribute to this important effort. Eaton’s Vehicle Group continues to implement ZWTL initiatives at its sites around the world. In 2020, its Hastings, Nebraska, facility was added to its list of manufacturing sites that are zero waste-to-landfill certified, bringing the global Vehicle Group sites that are ZWTL compliant to 74 percent.
“We are extremely proud of how we’ve come together to upgrade our manufacturing facilities in a way that improves energy efficiency, minimizes the impact on the environment, and brings us closer to a carbon-free future,” said João Faria, president, Eaton’s Vehicle Group. “Our commitment to sustainability is part of our core mission to improve the quality of life and the environment for those who count on us today and in the decades to come.”
Read more about Eaton’s commitment to sustainability in its latest Sustainability Report.
Learn more about how Eaton is helping its customers conserve resources and reduce their carbon footprint.
Eaton’s mission is to improve the quality of life and the environment through the use of power management technologies and services. We provide sustainable solutions that help our customers effectively manage electrical, hydraulic, and mechanical power – more safely, more efficiently, and more reliably. Eaton’s 2019 revenues were $21.4 billion, and we sell products to customers in more than 175 countries. We have approximately 92,000 employees. For more information, visit www.eaton.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201015005246/en/
Contact information
Thomas Nellenbach
thomasjnellenbach@eaton.com
(216) 333-2876 (cell)
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
